CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $182,793
- in 3 filings
Net −$182,793. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-04 | Schoenberg Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −1,041 | 1,042 | ||
| 2020-09-03 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion | +8,807 | 192,693 | ||
| 2020-09-03 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −8,807 | 140,920 | ||
| 2020-09-01 | PFREUNDSCHUH PETER P. Chief Financial Officer | Exercise or conversion | +1,042 | 8,397 | ||
| 2020-09-01 | PFREUNDSCHUH PETER P. Chief Financial Officer | Sale | −509 | $22.82 | $12K | 7,888 |
| 2020-09-01 | PFREUNDSCHUH PETER P. Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −1,042 | 4,166 | ||
| 2020-08-03 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion | +8,807 | 183,886 | ||
| 2020-08-03 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −8,807 | 149,727 | ||
| 2020-07-27 | PFREUNDSCHUH PETER P. Chief Financial Officer | Sale | −141 | $23.51 | $3K | 7,355 |
| 2020-07-27 | Schoenberg Mark Chief Medical Officer | Sale | −70 | $23.51 | $2K | 18,543 |
| 2020-07-26 | PFREUNDSCHUH PETER P. Chief Financial Officer | Exercise or conversion | +417 | 7,496 | ||
| 2020-07-26 | PFREUNDSCHUH PETER P. Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −417 | 2,500 | ||
| 2020-07-26 | Schoenberg Mark Chief Medical Officer | Exercise or conversion | +209 | 18,613 | ||
| 2020-07-26 | Schoenberg Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −209 | 1,250 | ||
| 2020-07-03 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion | +8,807 | 175,079 | ||
| 2020-07-03 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −8,807 | 158,534 | ||
| 2020-06-08 | Tomasello Shawn Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2020-06-08 | Nussbaum Ran Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2020-06-08 | Holden Stuart Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2020-06-08 | FALBERG KATHRYN E Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 |
Page 20 of 25 · 496 trades